NCT04366960View on ClinicalTrials.gov

Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

May 25, 2021

Study Completion Date

May 25, 2021

Conditions
Covid19
Interventions
DRUG

Enoxaparin

Subcutaneous enoxaparin

Trial Locations (1)

20162

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan

All Listed Sponsors
lead

Niguarda Hospital

OTHER

NCT04366960 - Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients | Biotech Hunter | Biotech Hunter